Synthetic blood vessel repair after arm or leg injury
Part of Heart & circulation, Injuries & trauma clinical trials.
This study tests a new synthetic blood vessel called Symvess to restore blood flow after a serious arm or leg injury. It aims to see how well it works in real-life situations and if it is safe for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have an injury to a major artery in your arm or leg that needs urgent repair.
- You can give informed consent or have a legal representative who can.
- You are expected to live for at least one year (as judged by the doctor).
- You have a stable place to live and are able to attend follow-up visits for one year.
- You have confirmed health insurance.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a man-made blood vessel called SYMVESS to repair a serious injury to an artery in the arm or leg. It is for teenagers whose own veins cannot be used, and the goal is to save the limb.
This trial studies whether a newer “tissue-engineered” blood vessel graft is safe and works well in children who need a specific heart surgery connection outside the heart. It may help by offering a new type of graft, but your team will screen for size and medical factors first.
This trial tests a lab-made blood vessel (called an ATEV) used as a bypass graft during heart surgery. The ATEV is designed for people who don't have enough healthy leg vein for standard bypass grafts, and it may help restore blood flow to the heart more safely.
This trial tests a new synthetic blood vessel graft that connects an artery to a vein in your arm to create a reliable spot for dialysis. It's for people with kidney failure who need long-term dialysis but can't have the usual fistula made from their own blood vessels.
This trial tests a man-made blood vessel (CTEV) as a new option for bypass grafts in people who need heart bypass surgery. It aims to see if the CTEV is safe and effective for improving blood flow to the heart.
This trial studies a new stent-like vascular scaffold to improve blood flow in people with symptomatic blockage in the thigh/knee artery. It may help reduce symptoms from narrowed or blocked arteries, but you must meet several artery and health requirements.
Hear when a new Vascular Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.